Identification and Verification of Potential Therapeutic Target Genes in Berberine-Treated Zucker Diabetic Fatty Rats through Bioinformatics Analysis
Fig 2
Effect of daily oral administration of berberine for 12 consecutive weeks on the level of glycosylated hemoglobin (HbA1C).
▲▲P<0.01 versus the control group; ★P<0.05, ★★P<0.01 versus the DM group. The data presented are the mean values ± SD, number of rats per group n = 6.